Irem Karaomerlioglu | Health Technology Assessment Unit Supervisor
Turkish Medicines and Medical Devices Agency

Dr İrem Karaömerlioğlu is the Head of the Health Technology Assessment Unit at the Turkish Medicines and Medical Devices Agency (TİTCK) in Türkiye. She has extensive experience in health technology assessment, health economics, market access, pharmaceutical pricing and reimbursement. She has worked at different stages of the market access pathway, including on early access programmes, named-patient programmes, pharmaceutical pricing, pharmacovigilance and HTA.  In her current role, she leads HTA assessments in support of evidence-based reimbursement decisions, including the evaluation of clinical, economic and real-world evidence. Her professional interests include value-based decision-making, fair pricing and reimbursement, real-world evidence, and sustainable access to innovative medicines. Actively involved in international HTA and health economics networks, she brings a public-sector and HTA perspective from Türkiye to discussions on healthcare policy, market access and the value of medicines at an international level.